ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
antibody
|
943 |
416K |
5 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
943
|
416K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
11 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
29 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
32 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
antibody
|
1.3K |
430K |
5 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
1.3K
|
430K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
9 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
35 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
35
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
35 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Confirmatory Phase 3 Back Pain Trial Actively Enrols
|
|
antibody
|
47 |
22K |
17 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
47
|
22K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
6 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
3 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
32 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
12K |
3.9M |
4 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
24 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
28 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
29 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
26 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
antibody
|
1.3K |
430K |
7 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
1.3K
|
430K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
antibody
|
1.3K |
430K |
13 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
1.3K
|
430K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
36 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
antibody
|
67 |
25K |
1 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
25K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
19 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
28 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
7 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
3 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
10 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
20 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
31 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
antibody
|
265 |
109K |
9 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
109K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
antibody
|
265 |
109K |
9 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
109K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
49 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
81 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
81
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
16 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
44 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
44
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
30 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
41 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
41
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
12K |
3.9M |
16 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
44 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
44
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
46 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
46
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
17 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
34 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
34
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
18 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
32 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
6 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
32 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
32 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
32 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
16 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
6.0K |
3.0M |
46 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
46
|
|